Results 151 to 160 of about 7,041 (257)

Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet. [PDF]

Pharmaceutics
Yoon JH, Kim DH, Kim JE.
europepmc   +1 more source

How Common Is Hypercortisolism in Patients With Hypertension? Risk Factors, Epidemiology, and Making a Diagnosis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Endogenous hypercortisolism (EHC) is an underrecognised and clinically significant contributor to hypertension, particularly resistant hypertension. Once viewed as a rare entity, EHC is now understood as a spectrum of cortisol excess associated with adverse cardiometabolic outcomes and target‐organ damage.
Omar Al Dhaybi, Deepak L. Bhatt
wiley   +1 more source

<i>In Vitro</i> Liver Models for Studying Pharmaceutical Metabolism in Fish - A Critical Analysis of Their Applications and Limitations. [PDF]

Environ Sci Technol
Matthee C, Pihlaja TLM, Järvinen P, Brown AR, Lange A, Sikanen TM, Tyler CR.   +6 more
europepmc   +1 more source

Protection of Hygroscopic Pharmaceutical and Nutraceutical Active Ingredients via Film Coating Technologies: A Review. [PDF]

Drug Des Devel Ther
Pitriani P, Mulyani AT, Wardhana YW, Chaerunisaa AY.   +3 more
europepmc   +1 more source

Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the feasibility and preliminary efficacy of a 12‐week remotely‐delivered exercise snacks (ES) intervention in adults with type 2 diabetes. Material and Methods Insufficiently active adults with type 2 diabetes (N = 69; 46 females; mean age ± SD: 58 ± 11 years) were randomised to an ES or mobility/stretching comparator group
Fiona J. Babir, Alexis Marcotte‐Chénard, Roderick E. Sandilands, Kaja Falkenhain, Noah Mulkewich, Hashim Islam, Seth F. McCarthy, Douglas L. Richards, Kenneth Madden, Joel Singer, Michael C. Riddell, Mary E. Jung, Martin J. Gibala, Jonathan P. Little   +13 more
wiley   +1 more source

Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes. [PDF]

Cureus
Teli B, Somani S, Arya V, Rajput PJ, Kahale P, Bharmal V, Shah S, Patel V, Ahuja A, Patange S.   +9 more
europepmc   +1 more source

Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Achieving glucose targets without hypoglycaemia is the treatment goal in type 1 diabetes. Structured education, intensified insulin injection regimens, continuous glucose monitoring, automated insulin delivery, and ongoing support from a multidisciplinary team all support people with type 1 diabetes to achieve this goal. Despite these advances,
Nick Oliver, Bernhard Gehr, Rayhan Lal, Peter R. van Dijk, Eric Renard   +4 more
wiley   +1 more source

In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia. [PDF]

BMC Pharmacol Toxicol
Welegebrial BG, Gezae Z, Gebrekidan SK, Gebrerufael GG, Gebregzabiher HA, Kidane AM, Hailesilase GG.   +6 more
europepmc   +1 more source

Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiovascular autonomic neuropathy (CAN) is a severe form of diabetic neuropathy affecting approximately one in five people with diabetes and is a major predictor of cardiovascular mortality. Low‐grade inflammation may contribute to CAN development, but the exact inflammatory factors associated with CAN remain unclear.
Michelle Damgaard, Marietta Kokla, Rebekka H. Gerwig, Hatice Isik Mizrak, Sofie Korsgaard Hecquet, Tik Muk, Gurjeet Kaur, Birgitte Brock, Christian Stevns Hansen, Joachim Størling   +9 more
wiley   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source